Fog Pharmaceuticals Funding: $506M Raised, Series E (2024)
Fog Pharmaceuticals is based in Cambridge. It has raised $506M in total funding. Latest round: Series E.
Fog Pharmaceuticals funding overview
Fog Pharmaceuticals is based in Cambridge. Fog Pharmaceuticals has raised $506M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in February 2024. The round record for Fog Pharmaceuticals runs through 2024; nothing later has been disclosed. Investors on record include 6 Dimensions Capital, GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group, Leerink Partners. 6 distinct backers are named across the disclosed rounds.
Fog Pharmaceuticals at a glance
Total raised
$506M
Latest round
Series E
Latest round date
February 2024
Headquarters
Cambridge
Notable investors
6 Dimensions Capital, GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group, Leerink Partners
Frequently asked about Fog Pharmaceuticals funding
How much has Fog Pharmaceuticals raised?
Fog Pharmaceuticals has raised $506M in total disclosed funding across the rounds on record.
Who has invested in Fog Pharmaceuticals?
6 Dimensions Capital, GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group, Leerink Partners are named among the investors backing Fog Pharmaceuticals.
What was the latest Fog Pharmaceuticals funding round?
The most recent disclosed round is a Series E, announced in February 2024.
Where is Fog Pharmaceuticals based?
Fog Pharmaceuticals is based in Cambridge.
When did Fog Pharmaceuticals last raise?
The last disclosed Fog Pharmaceuticals round closed in February 2024 at Series E.
Totals shown for Fog Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
